alpha-naphthoflavone has been researched along with 1,2,5,6-dibenzanthracene in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dutour, R; Poirier, D | 1 |
| Alworth, WL; Slaga, TJ | 1 |
1 review(s) available for alpha-naphthoflavone and 1,2,5,6-dibenzanthracene
| Article | Year |
|---|---|
Inhibitors of cytochrome P450 (CYP) 1B1.
Topics: Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Humans; Molecular Structure; Structure-Activity Relationship | 2017 |
1 other study(ies) available for alpha-naphthoflavone and 1,2,5,6-dibenzanthracene
| Article | Year |
|---|---|
Effects of ellipticine, flavone, and 7,8-benzoflavone upon 7,12-dimethylbenz[a]anthracene, 7,14-dimethyldibenzo[a,h]anthracene and dibenzo[a,h]anthracene initiated skin tumors in mice.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Alkaloids; Animals; Benz(a)Anthracenes; Benzoflavones; Dose-Response Relationship, Drug; Ellipticines; Female; Flavonoids; Mice; Skin Neoplasms | 1985 |